Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hugo M Horlings

Showing results (1-10 of 103) with videos related to

Pageof 11
Sort By:
Cancers|January 20, 2021
A High-Dimensional Window into the Micro-Environment of Triple Negative Breast CancerIris Nederlof, Hugo M Horlings, Christina Curtis, et al.
The Journal of Pathology|April 14, 2015
Categorization of cancer through genomic complexity could guide research and management strategiesHugo M Horlings, Adrienne M Flanagan, David G Huntsman
Science Translational Medicine|July 2, 2010
Translating the genomic architecture of breast cancer into clinical applicationsHugo M Horlings, C Dilara Savci-Heijink, Marc J van de Vijver
Proceedings of the National Academy of Sciences of the United States of America|October 21, 2009
Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neckMarta Persson, Ywonne Andrén, Joachim Mark, et al.
Gynecologic Oncology Reports|June 16, 2015
Low grade serious carcinoma of the peritoneum in a BRCA1 carrier previously diagnosed with a "low-grade serous tubal intra-epithelial carcinoma" (STIC) on risk reducing surgeryWen Yee Chay, Hugo M Horlings, Anna V Tinker, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 28, 2009
Mucinous and neuroendocrine breast carcinomas are transcriptionally distinct from invasive ductal carcinomas of no special typeBritta Weigelt, Felipe C Geyer, Hugo M Horlings, et al.
NPJ Digital Medicine|July 2, 2025
H&E to IHC virtual staining methods in breast cancer: an overview and benchmarkingPascal Klöckner, José Teixeira, Diana Montezuma, et al.
Breast Cancer Research and Treatment|March 31, 2015
Retrospective analysis of metastatic behaviour of breast cancer subtypesC Dilara Savci-Heijink, Hans Halfwerk, Gerrit K J Hooijer, et al.
Plos One|July 19, 2012
Integration of clinical and gene expression data has a synergetic effect on predicting breast cancer outcomeMartin H van Vliet, Hugo M Horlings, Marc J van de Vijver, et al.
The Oncologist|June 26, 2024
High expression of phosphoglycerate dehydrogenase predicts poor outcome in patients with high-grade serous ovarian cancerLilian van Wagensveld, Tom Van Nyen, Daniela Annibali, et al.
Pageof 11

Showing results (1-10 of 103) with videos related to

Sort By:
Pageof 11
Cancers|January 20, 2021
A High-Dimensional Window into the Micro-Environment of Triple Negative Breast CancerIris Nederlof, Hugo M Horlings, Christina Curtis, et al.
The Journal of Pathology|April 14, 2015
Categorization of cancer through genomic complexity could guide research and management strategiesHugo M Horlings, Adrienne M Flanagan, David G Huntsman
Science Translational Medicine|July 2, 2010
Translating the genomic architecture of breast cancer into clinical applicationsHugo M Horlings, C Dilara Savci-Heijink, Marc J van de Vijver
Proceedings of the National Academy of Sciences of the United States of America|October 21, 2009
Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neckMarta Persson, Ywonne Andrén, Joachim Mark, et al.
Gynecologic Oncology Reports|June 16, 2015
Low grade serious carcinoma of the peritoneum in a BRCA1 carrier previously diagnosed with a "low-grade serous tubal intra-epithelial carcinoma" (STIC) on risk reducing surgeryWen Yee Chay, Hugo M Horlings, Anna V Tinker, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 28, 2009
Mucinous and neuroendocrine breast carcinomas are transcriptionally distinct from invasive ductal carcinomas of no special typeBritta Weigelt, Felipe C Geyer, Hugo M Horlings, et al.
NPJ Digital Medicine|July 2, 2025
H&E to IHC virtual staining methods in breast cancer: an overview and benchmarkingPascal Klöckner, José Teixeira, Diana Montezuma, et al.
Breast Cancer Research and Treatment|March 31, 2015
Retrospective analysis of metastatic behaviour of breast cancer subtypesC Dilara Savci-Heijink, Hans Halfwerk, Gerrit K J Hooijer, et al.
Plos One|July 19, 2012
Integration of clinical and gene expression data has a synergetic effect on predicting breast cancer outcomeMartin H van Vliet, Hugo M Horlings, Marc J van de Vijver, et al.
The Oncologist|June 26, 2024
High expression of phosphoglycerate dehydrogenase predicts poor outcome in patients with high-grade serous ovarian cancerLilian van Wagensveld, Tom Van Nyen, Daniela Annibali, et al.
Pageof 11